60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP) is a publicly traded Healthcare sector company. As of May 21, 2026, SXTP trades at $1.38 with a market cap of $3.80M and a P/E ratio of -0.12. SXTP moved -1.42% today. Year to date, SXTP is -28.86%; over the trailing twelve months it is -85.23%. Its 52-week range spans $1.29 to $49.80. Analyst consensus is buy with an average price target of $14.10. Rallies surfaces SXTP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
SXTP financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. SXTP recently traded at $1.38. Market cap is $3.80M. P/E ratio is -0.12. Revenue is $1.01M.
| Metric | Value |
|---|---|
| Price | $1.38 |
| Market Cap | $3.80M |
| P/E Ratio | -0.12 |
| EPS | $-11.73 |
| Dividend Yield | 0.00% |
| 52-Week High | $49.80 |
| 52-Week Low | $1.29 |
| Volume | 1.47K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.01M |
| Net Income | $-7.37M |
| Gross Margin | 22.26% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $1.01M | $-7.37M | $-11.73 |
| 2024 | $607.57K | $-7.96M | $-18.55 |
| 2023 | $253.57K | $-3.81M | $-0.99 |
2 analysts cover SXTP: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $14.10.